- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07519369
Monitoring Daily Mobility in Children With Autism (SIMBA)
April 2, 2026 updated by: IRCCS San Raffaele Roma
Innovative Solution With Wearable Sensors for Monitoring Daily Mobility in Children With Autism
Children with autism spectrum disorder (ASD) often show motor abnormalities and sleep disturbances that affect behavior, learning, and family quality of life.
Emerging technologies such as wearable devices and markerless systems provide accessible tools for gait and sleep assessment, with actigraphy recommended for long-term monitoring in natural settings.
Evidence also suggests links between sleep problems and sensory processing differences.
This project, aims to integrate these approaches in a clinical-translational framework.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study aims to better understand how children with autism spectrum disorder (ASD) move and sleep in their everyday lives, and how these aspects may be connected to their overall development and well-being.
Children with ASD often experience differences in motor skills, such as walking and coordination, as well as sleep difficulties, which can affect their behavior, learning, and family life.
To address these challenges, the study uses innovative and non-invasive technologies, including wearable devices (such as wrist sensors and smart insoles) and video-based systems that can analyze movement without the need for markers or complex laboratory setups.
These tools allow researchers to monitor children in more natural environments, such as at home, over several days.
The project combines three main components: continuous monitoring of daily activity through wearable sensors, detailed gait analysis in a clinical setting, and sleep evaluation using both wearable devices and home-based sleep recordings.
By integrating these data, the study seeks to identify patterns in movement and sleep, and to explore how they relate to sensory processing differences often seen in children with ASD.
The ultimate goal is to develop more personalized and accessible approaches to assessment and care, helping clinicians and families better understand each child's needs and support their development through targeted interventions.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
RM
-
Roma, RM, Italy, 00163
- Recruiting
- IRCCS San Raffaele
-
Contact:
- Federico Vigevano, MD
- Phone Number: +39 06660581
- Email: federico.vigevano@sanraffaele.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Diagnosis of autism spectrum disorder (ASD) according to DSM-5 criteria
- Age between 2 and 18 years
- Ability to walk independently
- Willingness to wear a wearable device (wrist sensor) continuously for 7 days and pedobarographic insoles for reproducible gait monitoring
- Willingness to undergo one night of home polysomnography with video-EEG/polygraphy during the wearable monitoring period
- Informed consent signed by both parents/legal guardian; assent from the minor when applicable
Exclusion Criteria:
- Skin contraindications to the wristband/fixation systems (known material allergies, active wrist dermatitis, or skin lesions preventing prolonged use)
- Severe motor impairments
- Recent orthopedic surgery (<6 months)
- Use of orthoses or assistive devices during walking
- Severe behavioral disorder making device use impracticable despite acclimatization strategies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ASD patient cohort
|
The project integrates three complementary modules on the same participant: (A) monitoring with wearable sensors (primary objective), (B) laboratory-based gait analysis, and (C) sleep assessment using home video-EEG polysomnography (PSG).
The reference wearable instrumentation follows the technical protocols established by the Politecnico di Milano, which already include the use of the AX6 device and F-Scan GO insoles among the wearable devices available within the research program.
Other Names:
|
|
Active Comparator: cohort of healthy controls
|
The project integrates three complementary modules on the same participant: (A) monitoring with wearable sensors (primary objective), (B) laboratory-based gait analysis, and (C) sleep assessment using home video-EEG polysomnography (PSG).
The reference wearable instrumentation follows the technical protocols established by the Politecnico di Milano, which already include the use of the AX6 device and F-Scan GO insoles among the wearable devices available within the research program.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility and adherence to continuous use of a wearable sensor in children with autism spectrum disorder (ASD)
Time Frame: 7 days
|
This objective aims to assess the feasibility and adherence to continuous use of a wearable sensor in children with autism spectrum disorder (ASD), evaluating tolerability, compliance, and data quality in real-life conditions over a 7-day monitoring period.
Feasibility is primarily defined as the proportion of participants completing the protocol with valid data, while adherence is assessed through wear time, data completeness, and caregiver-reported acceptability.
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gait Pattern
Time Frame: during the enrollment period with wearable sensor
|
To characterize gait patterns in children and adolescents with autism spectrum disorder
|
during the enrollment period with wearable sensor
|
|
ASD subgroups
Time Frame: during the enrollment period using the wearable sensor
|
To identify potential phenotypic subgroups within the ASD population (e.g., different gait patterns according to age or phenotypic severity)
|
during the enrollment period using the wearable sensor
|
|
Daily activity and sleep quality
Time Frame: during the enrollment period using a wearable sensor
|
To investigate the relationship between sleep quality, daily motor activity (daytime activity, fragmentation/variability), and sensory processing.
|
during the enrollment period using a wearable sensor
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 18, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Study Registration Dates
First Submitted
April 2, 2026
First Submitted That Met QC Criteria
April 2, 2026
First Posted (Actual)
April 9, 2026
Study Record Updates
Last Update Posted (Actual)
April 9, 2026
Last Update Submitted That Met QC Criteria
April 2, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Central Nervous System Diseases
- Nervous System Diseases
- Mental Disorders
- Neurodevelopmental Disorders
- Child Development Disorders, Pervasive
- Autism Spectrum Disorder
- Movement Disorders
- Diagnostic Techniques and Procedures
- Diagnosis
- Population Characteristics
- Physical Examination
- Health
- Monitoring, Physiologic
- Physical Fitness
- Gait
- Physical Functional Performance
- Polysomnography
- Gait Analysis
Other Study ID Numbers
- 425/SR/25
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder (ASD
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAutism Spectrum Disorder (ASDFrance
-
Holistic Homoeopathic Clinic and Research CenterCompleted
-
Université Catholique de LouvainNot yet recruiting
-
Semmelweis UniversityRecruitingAutism Spectrum Disorder (ASD)Hungary
-
University of BariActive, not recruitingAutism Spectrum Disorder (ASDItaly
Clinical Trials on placement of a wearable wrist sensor
-
Guangzhou Institute of Respiratory DiseaseRecruiting
-
Oxitone Medical Ltd.The London Sleep CentreUnknownObstructive Sleep ApneaUnited Kingdom
-
IMDEA FoodAbbott Laboratories (Pak) Ltd.Not yet recruitingPrediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Artificial Intelligence Mobile Application
-
MedRhythms, Inc.Johns Hopkins University; Sargent College of Health and Rehabilitation SciencesCompletedParkinson DiseaseUnited States
-
University of AarhusRanders Regional HospitalTerminatedCatheter-Related Infections | Cesarean Section; InfectionDenmark
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Germany, Netherlands, Belgium
-
Cui XiaobingNot yet recruitingAmpullary Adenoma | Ampullary Carcinoma | Ampulla of Vater Neoplasms
-
Mayo ClinicAirCast LLCTerminated
-
Zywie, Inc.Completed
-
University of Maryland, BaltimoreThe University of Texas Health Science Center, HoustonNot yet recruitingTraumatic Brain Injury